Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Use of 4F-PCC in Severe Traumatic Hemorrhage
NCT05738642Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in severe trauma, traumatic hemorrhage and Traumatic shock (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Incidence of multiple organ failure at 7 days and Day 28-mortality. Started Aug 2023; status: completed.
02
Conditions
severe traumatraumatic hemorrhageTraumatic shock
Beyond the preview
Go deeper on NCT05738642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05738642.